Pityriasis Rubra PilarisSymptoms, Doctors, Treatments, Advances & More
Learn About Pityriasis Rubra Pilaris
Condition 101 content is not available at this time, but we are continually updating the site. Please check back.
However, there may be experts who have treated this or similar conditions in our Find a Doctor section and research may be available in our Latest Advances section.
Ruth Vleugels is a Dermatologist practicing medicine in Boston, Massachusetts. Dr. Vleugels is rated as an Elite provider by MediFind in the treatment of Pityriasis Rubra Pilaris. She is also highly rated in 26 other conditions, according to our data. Her clinical expertise encompasses Dermatomyositis, Eosinophilic Fasciitis, Cutaneous Lupus Erythematosus (CLE), and Discoid Lupus Erythematosus (DLE). Dr. Vleugels is board certified in Dermatology.
Teri Greiling is a Dermatologist practicing medicine in Portland, Oregon. Dr. Greiling is rated as an Elite provider by MediFind in the treatment of Pityriasis Rubra Pilaris. She is also highly rated in 12 other conditions, according to our data. Her clinical expertise encompasses Pityriasis Rubra Pilaris, Acrokeratoelastoidosis of Costa, Palmoplantar Keratoderma, and Cicatricial Pemphigoid.
Dermatopathology Lab Hup
Dylan Haynes is a Dermatologist practicing medicine in Philadelphia, Pennsylvania. Dr. Haynes is rated as an Elite provider by MediFind in the treatment of Pityriasis Rubra Pilaris. He is also highly rated in 5 other conditions, according to our data. His clinical expertise encompasses Pityriasis Rubra Pilaris, Palmoplantar Keratoderma, Acrokeratoelastoidosis of Costa, and Atopic Dermatitis.
Summary: The purpose of this study is to evaluate the safety and effectiveness of Deucravacitinib (BMS-986165) in Pityriasis Rubra Pilaris as assessed by the change in Investigator Global Assessment (IGA), PASI- 50, 75, 90, DLQI, NRS itch, and Skindex-16 at week 24. To predict responses through the identification of unique biomarkers of PRP utilizing single-cell RNA sequencing.